inert 1 MG Oral Tablet
- RxCUI
- 748797
- RxNorm name
- inert 1 MG Oral Tablet
- Display name
- inert 1 MG Oral Tablet
- Full name
- inert 1 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sprintec | NORGESTIMATE AND ETHINYL ESTRADIOL | Preferred Pharmaceuticals, Inc. | 90240210-0bca-4a55-99dc-19f2b40d8e3f | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 748797 |
| SLYND | DROSPIRENONE | Exeltis USA, Inc. | db32bc55-f295-4d87-9dbb-0a2f45573dcf | 2026-08-27 | Warnings, Adverse reactions | 748797 |
| Isibloom | DESOGESTREL AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 4a8f278f-f505-4537-8deb-74e8927df8c6 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | e0b07fb6-8dbd-4e5d-b589-5191a1dc02ae | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Redpharm Drug | 57d1d945-9fc9-4e79-e063-6294a90a738a | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 748797 |
| norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | 2385591b-70ee-0577-e063-6394a90a9357 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Desogestrel and Ethinyl Estradiol | DESOGESTREL AND ETHINYL ESTRADIOL | Camber Pharmaceuticals, Inc. | 78454ebf-f1a3-4ca0-b32e-88c51bc57773 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIORELE | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6422dcc3-959a-4590-9ca8-9dcb58e68253 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| MONO-LINYAH | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 2ec8f18f-297c-405f-b191-a40767366bad | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Turqoz | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | e7a05138-91a5-4c66-a915-614576e0805a | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Kurvelo | LEVONORGESTREL AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 752f525e-1838-4058-9ab7-2c2d91f86dfd | 2026-05-20 | Boxed warning, Warnings | 748797 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | DROSPIRENONE AND ETHINYL ESTRADIOL | Apotex Corp. | 9187a357-e95d-4733-9627-f19522b86373 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Wera | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | 638e4f36-1a27-4220-8ec9-3fa9d9b36c11 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Dasetta 7/7/7 | NORETHINDRONE AND ETHINYL ESTRADIOL | Northstar Rx LLC | da52e74a-1baf-4a33-a068-b49176700320 | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Vestura | DROSPIRENONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals, Inc. | c6f63cc0-11b0-4320-a9ef-5bd5c9b16fd5 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Cryselle | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f73ece43-6b5f-4abb-ba6d-4d62775f2f8e | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 35c6507c-555a-45ed-aaf6-8695831de71a | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| VIENVA TM | LEVONORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | f6825c1a-ba78-47aa-9622-12e59517ab1a | 2026-03-03 | Warnings, Adverse reactions | 748797 |
| drospirenone and ethinyl estradiol | DROSPIRENONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6edead7f-a41f-4d0b-a27a-b2047ed4eea0 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Lutera | LEVONORGESTREL AND ETHINYL ESTRADIOL | Dr. Reddys Laboratories Inc. | 47fc432b-2259-47d2-bba9-5e3aae583990 | 2026-02-13 | Warnings, Adverse reactions | 748797 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| da52e74a-1baf-4a33-a068-b49176700320 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 14 | DASETTATM 7/7/7 (norethindrone/ethinyl estradiol Tablets, USP) | 20260414 |
| c3c00dc0-8834-45fb-9f5b-810a98cef59d | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 14 | Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1 mg/0.02 mg | 20220831 |
| c0e2c5b4-70ac-4b41-aa71-00e506dbb72f | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 13 | BRIELLYN ® (Norethindrone and Ethinyl Estradiol Tablets, USP) | 20260131 |
| 5eecfd2c-4bda-4349-b634-199a354fa996 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 13 | Turqoz TM (norgestrel and ethinyl estradiol tablets USP) 0.3 mg/0.03 mg | 20251205 |
| d9252820-131a-4870-8b11-945d1bfd5659 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 13 | These highlights do not include all the information needed to use SPRINTEC safely and effectively. See full prescribing information for SPRINTEC. SPRINTEC ® (norgestimate/ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20241219 |
| 22cfceff-0429-466f-a015-33cfdc505d44 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 13 | These highlights do not include all the information needed to use TRI-MILI safely and effectively. See full prescribing information for TRI-MILI. Tri-Mili ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240102 |
| a9e08f9b-9862-4c2c-8302-53dc82d85126 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 13 | Apri ® (desogestrel and ethinyl estradiol tablets USP) | 20211215 |
| 752f525e-1838-4058-9ab7-2c2d91f86dfd | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | Kurvelo™ (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/30 mcg)Rx only | 20260520 |
| 35c6507c-555a-45ed-aaf6-8695831de71a | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.25 mg/0.035 mg, for oral use NORGESTIMATE and ETHINYL ESTRADIOL tablets, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, for oral use Initial U.S. Approval: 1989 | 20260303 |
| 6edead7f-a41f-4d0b-a27a-b2047ed4eea0 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS. DROSPIRENONE and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 2001 | 20260303 |
| bfadc9b6-1dd6-4bf3-af5f-b50fbdae55d3 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | Dasetta 1/35 | 20251205 |
| 76f14485-321d-4d4f-a3b0-aab195fd0dd1 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | These highlights do not include all the information needed to use MILI safely and effectively. See full prescribing information for MILI. MILI ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20241207 |
| 25f9b952-cc1d-454e-a3ec-834ba1774b6b | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS. DROSPIRENONE and ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 2001 | 20230922 |
| 4701e72b-6378-a771-fb88-1b703031a8bc | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | ALTAVERA ® Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg and 0.03 mg Rx only | 20230210 |
| cfa297a6-1cc7-4751-b8ea-0e57965f1ca9 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | Kelnor ® 1/35 (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets USP) | 20230204 |
| a3ce5125-62ba-4983-93f0-91f254271605 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 12 | Velivet ® (desogestrel and ethinyl estradiol tablets USP - triphasic regimen) Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. | 20220927 |
| b71a2b34-95bf-4430-83a0-1a4d1218ea3c | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | These highlights do not include all the information needed to use Tri-Linyah safely and effectively. See full prescribing information for Tri-Linyah. Tri-Linyah (norgestimate/ethinyl estradiol) tablets, for oral use. Initial U.S. Approval: 1989 | 20251205 |
| de9a2d1b-15f6-453f-b36b-1c2a43c4918d | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | Rx only | 20251118 |
| 655b2c93-cfae-d44f-c128-c816bbd88e45 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | These highlights do not include all the information needed to use JOYEAUX ® tablets and ferrous fumarate tablets safely and effectively. See full prescribing information for JOYEAUX ® tablets and ferrous fumarate tablets. JOYEAUX ® (levonorgestrel and ethinyl estradiol tablets and ferrous fumarate tablets ) for oral administration Initial U.S. Approval: 1997 | 20241018 |
| 4161f614-6e55-4114-87f7-19bb77f6b09b | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | SIMLIYA TM (desogestrel and ethinyl estradiol tablets, USP and ethinyl estradiol tablets, USP) 0.15 mg/0.02 mg and 0.01 mg Rx only | 20241009 |
| 1a3211f8-41f5-4905-a466-0d79add5fdad | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | These highlights do not include all the information needed to use JASMIEL safely and effectively. See full prescribing information for JASMIEL. JASMIEL ® (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20240514 |
| 33b895e4-b467-41b1-a812-8068cc5bb93e | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | Nortrel ® (norethindrone and ethinyl estradiol tablets USP) | 20240507 |
| 0beef9d3-8326-48cf-b89a-fa794902c6c1 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | Aranelle ® (norethindrone and ethinyl estradiol tablets, USP) | 20230131 |
| 563297dc-f27b-46e3-83de-bade17473d62 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | Rx only Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg/50 mcg Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases . | 20211218 |
| 5acb5f67-c6cc-4fd6-8702-92e2974023de | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 11 | ORSYTHIA ® (LEVONORGESTREL (0.1 mg) AND ETHINYL ESTRADIOL (0.02 mg) TABLETS USP) | 20171122 |
| 5c02b4d3-1e2f-439a-ae45-02304ee190d1 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | ALYACEN 7/7/7(Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35(Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) | 20260131 |
| c25cd86c-2940-475a-9628-ee75b0294e8d | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS. NORGESTIMATE AND ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 1989 | 20251209 |
| 4c59652c-49a6-4eed-b557-9abd3ffac541 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | Chateal EQ ® (Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg) Rx only | 20250801 |
| 61207a91-8b3c-4231-b98f-3cb9f4a4be09 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | Aubra EQ® (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.1 mg/0.02 mg Rx only Patients should be counseled that oral contraceptives do not protect against transmission of HIV (AIDS) and other sexually transmitted diseases (STDs) such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. | 20250801 |
| dd6122cd-b7ba-4fe3-bde5-910882475b67 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | Afirmelle TM (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.1 mg/0.02 mg Rx only Patients should be counseled that oral contraceptives do not protect against transmission of HIV (AIDS) and other sexually transmitted diseases (STDs) such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. | 20250801 |
| 31679b9f-58c9-4bf1-8c2c-f5a216ff4cd3 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | LEVORA ® 0.15/30-28 (levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg tablets) | 20250724 |
| f59acc3e-21d9-4fa3-ad52-d77225739e1a | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | These highlights do not include all the information needed to use Tri-VyLibra safely and effectively. See full prescribing information for Tri-VyLibra. Tri-VyLibra ® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20240202 |
| 192ad3b0-9ef2-409d-a851-77712202c45a | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | These highlights do not include all the information needed to use ZUMANDIMINE safely and effectively. See full prescribing information for ZUMANDIMINE. ZUMANDIMINE ® (drospirenone and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 2001 | 20231009 |
| d9d2d0a1-b336-40ee-b4cc-b3d876ca91b9 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | These highlights do not include all the information needed to use TRI-LO-MILI® safely and effectively. See full prescribing information for TRI-LO-MILI. TRI-LO-MILI (norgestimate and ethinyl estradiol) tablets for oral use Initial U.S. Approval: 1989 | 20220908 |
| a5fd1b3a-019c-4871-95b3-a45bbbd46f82 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 10 | LESSINA ® (levonorgestrel and ethinyl estradiol tablets USP) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. 9014 Rx only | 20211216 |
| 0f8f8a21-cee8-462f-98b3-6c06f2f33e0d | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS safely and effectively. See full prescribing information for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS. DROSPIRENONE AND ETHINYL ESTRADIOL tablets, for oral use Initial U.S. Approval: 2001 | 20260129 |
| 6e686b50-8d36-4a13-91a8-d4ad21cdb735 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1 mg/0.02 mg | 20251209 |
| 00657f4e-9df8-4f58-91a0-eff5a467f988 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use ICLEVIA safely and effectively. See full prescribing information for ICLEVIA. ICLEVIA (levonorgestrel and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 1982 | 20240702 |
| 1ba8a8ab-eb09-0807-47d4-6b4055d10d91 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use Tri-Estarylla safely and effectively. See full prescribing information for Tri-Estarylla. Tri-Estarylla ® (norgestimate and ethinyl estradiol, USP) tablets, for oral use Initial U.S. Approval: 1989 | 20230801 |
| 59bce25b-ee2c-4f06-afff-e5141d063602 | inert 1 MG Oral Tablet [PSN] · inert ingredients 1 MG Oral Tablet [SCD] | 2 | 9 | These highlights do not include all the information needed to use FEMYNOR safely and effectively. See full prescribing information for FEMYNOR. FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989 | 20160530 |